
Labeta200 mg
Beximco Pharmaceuticals Ltd.
Labetalol Hydrochloride is a combined alpha-1 and non-selective beta-adrenergic blocking agent used for the following indications: Essential hypertension (FDA-approved and more.
Labetalol Hydrochloride is a combined alpha-1 and non-selective beta-adrenergic blocking agent used for the following indications:
Use of Labetalol Hydrochloride for any indication should be individualized and supervised by a qualified physician.
| Regimen | Dose |
|---|---|
| Initial dose | 100 mg twice daily, alone or added to existing diuretic therapy |
| Titration | Increase by 100 mg twice daily every 2-3 days as needed and tolerated |
| Usual maintenance dose | 200-400 mg twice daily |
| Severe hypertension | Up to 1,200-2,400 mg/day in divided doses in some patients, under close supervision |
| Elderly patients | May respond to lower doses (e.g., 100-200 mg twice daily); titrate cautiously |
| Method | Dose |
|---|---|
| Slow IV injection | 20 mg given slowly over 2 minutes; repeat doses of 40-80 mg at 10-minute intervals as needed, up to a total cumulative dose of 300 mg |
| Continuous IV infusion | Initiate at 1-2 mg/minute, titrated to blood pressure response; total dose generally 50-200 mg |
| Hypertension in pregnancy (specialist-directed) | Lower initial infusion rates (e.g., around 20 mg/hour) titrated carefully under obstetric/critical-care supervision |
Patients should transition from IV to oral Labetalol Hydrochloride as blood pressure stabilizes, under medical supervision. Labetalol Hydrochloride should always be administered exactly as prescribed; do not adjust the dose or stop treatment without consulting a physician.
Renal impairment: No specific dose adjustment is well-established; Labetalol Hydrochloride may be used with routine monitoring since it is primarily hepatically metabolized.
Hepatic impairment: Use with caution and close monitoring; Labetalol Hydrochloride is contraindicated in severe hepatic impairment/active liver disease (see Contraindications).
Common side effects of Labetalol Hydrochloride include:
Less common but serious side effects include severe hepatocellular injury (rare but potentially serious; see Precautions and Warnings), significant bradycardia, worsening heart failure, and bronchospasm in susceptible patients. Patients should seek medical attention promptly for yellowing of the eyes/skin, unexplained fatigue, dark urine, severe dizziness, fainting, or breathing difficulty while taking Labetalol Hydrochloride.
Labetalol Hydrochloride is contraindicated in patients with any of the following conditions:
Disclaimer
The information provided is accurate to the best of our knowledge, but it does not replace professional medical advice. We cannot guarantee its completeness or accuracy, and the absence of specific information about a drug should not be taken as an endorsement. We are not responsible for any consequences arising from this information, so please consult a healthcare professional for any concerns or questions.